HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 64 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,211,905 | +102.4% | 71,541 | +43.4% | 0.00% | 0.0% |
| Q2 2023 | $598,728 | -30.6% | 49,894 | -24.7% | 0.00% | 0.0% |
| Q1 2023 | $862,731 | +25.2% | 66,262 | +42.1% | 0.00% | 0.0% |
| Q4 2022 | $689,044 | +116.0% | 46,620 | +29.4% | 0.00% | – |
| Q3 2022 | $319,000 | +74.3% | 36,040 | +273.3% | 0.00% | – |
| Q1 2022 | $183,000 | -72.8% | 9,654 | -49.7% | 0.00% | -100.0% |
| Q4 2021 | $674,000 | -95.2% | 19,211 | -95.0% | 0.00% | -93.8% |
| Q3 2021 | $13,972,000 | -26.3% | 381,649 | -21.0% | 0.02% | -20.0% |
| Q2 2021 | $18,970,000 | +94.1% | 483,055 | +39.6% | 0.02% | +81.8% |
| Q1 2021 | $9,775,000 | +11.5% | 345,987 | +26.4% | 0.01% | 0.0% |
| Q4 2020 | $8,766,000 | +1.2% | 273,757 | +2.1% | 0.01% | 0.0% |
| Q3 2020 | $8,658,000 | – | 268,038 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |